CRESEMBA subst sèche 200 mg vial
7680661730015
CH-66173
J02AC05
08.06.0.
Reimbursement limitations:
CRESE.Lsg.IA
Aspergillose invasive (AI)
Cresemba est remboursé pour le traitement de l’AI chez les adultes et …
1 / 2
google
Details
- Product number
- 6617301
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- Praeparatio sicca: isavuconazonium 200 mg ut isavuconazonii sulfas, mannitolum, acidum sulfuricum, pro vitro.
Articles (1)
Cresemba 200mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
PRS
|
200.0 MG | Substance | Wirkstoff (Principe actif) |
|
PRS
|
- | Substance | WIZUS |
|
PRS
|
- | Substance | HNIDK |
|
PRS
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 640.25
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/03/2018
Authorization holder
Basilea Pharmaceutica
4123 Allschwil
Authorization information
- Swissmedic authorization number
- 66173
- Drug name
- Cresemba, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- PULPI
- ATC Code
- J02AC05
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 20/10/2017
- Authorization expiration date
- 31/12/9999
- IT number
- 08.06.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- CRESEMBA subst sèche 200 mg vial
- Description (DE)
- CRESEMBA Trockensub 200 mg Vial
- Market launch
- 20/10/2017
- Narcotic (BTM)
- No